Journal of Diabetes Research

Journal of Diabetes Research / 2015 / Article

Retraction | Open Access

Volume 2015 |Article ID 604986 | 1 page | https://doi.org/10.1155/2015/604986

Retracted: Prognostic Utility of Coronary Computed Tomographic Angiography: A 5-Year Follow-Up in Type 2 Diabetes Patients with Suspected Coronary Artery Disease

Received14 Jan 2015
Accepted14 Jan 2015
Published27 Jan 2015

The paper titled “Prognostic Utility of Coronary Computed Tomographic Angiography: A 5-Year Follow-Up in Type 2 Diabetes Patients with Suspected Coronary Artery Disease” [1], published in Journal of Diabetes Research, has been retracted as it is found to contain a substantial amount of material from the published paper “Value of multi-detector computed tomography angiography in predicting acute cardiac events in patients with type 2 diabetes” by Daliang Liu, Huijuan Jia, Wei Liu, Daqing Ma, Guangshan Tan, Wen He, Yucun Fu, and Le-Xin Wang, published in Experimental Therapeutic Medicine in April 2014.

References

  1. D. Liu, H. Jia, Y. Fu, W. He, and D. Ma, “Prognostic utility of coronary computed tomographic angiography: a 5-year follow-up in type 2 diabetes patients with suspected coronary artery disease,” Journal of Diabetes Research, vol. 2014, Article ID 103459, 7 pages, 2014. View at: Publisher Site | Google Scholar

Copyright © 2015 Journal of Diabetes Research. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

558 Views | 251 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.